Saltar al contenido
MilliporeSigma
Todas las fotos(1)

Documentos

47317

Sigma-Aldrich

Fmoc-Lys(Fmoc)-OH

≥98.0% (HPLC)

Sinónimos:

Nα,Nε-di-Fmoc-L-lysine

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

Fórmula empírica (notación de Hill):
C36H34N2O6
Número de CAS:
78081-87-5
Peso molecular:
590.66
Beilstein/REAXYS Number:
6034060
MDL number:
MFCD00080275
UNSPSC Code:
12352209
PubChem Substance ID:
57650922
NACRES:
NA.26

assay

≥98.0% (HPLC)

reaction suitability

reaction type: Fmoc solid-phase peptide synthesis

application(s)

peptide synthesis

functional group

Fmoc

storage temp.

2-8°C

SMILES string

OC(=O)[C@H](CCCCNC(=O)OCC1c2ccccc2-c3ccccc13)NC(=O)OCC4c5ccccc5-c6ccccc46

InChI

1S/C36H34N2O6/c39-34(40)33(38-36(42)44-22-32-29-17-7-3-13-25(29)26-14-4-8-18-30(26)32)19-9-10-20-37-35(41)43-21-31-27-15-5-1-11-23(27)24-12-2-6-16-28(24)31/h1-8,11-18,31-33H,9-10,19-22H2,(H,37,41)(H,38,42)(H,39,40)/t33-/m0/s1

InChI key

BMJRTKDVFXYEFS-XIFFEERXSA-N

Categorías relacionadas

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Joseph R Merrill et al.
Biomaterials, 84, 241-249 (2016-02-04)
Tumor angiogenesis, the formation of new tumor blood supply, has been recognized as a hallmark of cancer and represents an important target for clinical management of various angiogenesis-dependent solid tumors. Previously, by screening a bacteriophage peptide library we have discovered
Shafq Al-Azzawi et al.
International journal of molecular sciences, 19(10) (2018-10-21)
Alzheimer's disease (AD) is a progressive brain disorder and age-related disease characterised by abnormal accumulation of β-amyloid (Aβ). The development of drugs to combat AD is hampered by the lack of therapeutically-active molecules able to cross the blood-brain barrier (BBB).
Alex Abramov et al.
Molecules (Basel, Switzerland), 24(1) (2018-12-24)
In this work we have investigated the potential benefits of using supramolecular gel networks as reaction media to carry out air-sensitive metal-free light-induced trifluoromethylation of six-membered (hetero)arenes under aerobic conditions. This reaction was performed at room temperature (RT) using sodium
Andrew G Cheetham et al.
Acta pharmacologica Sinica, 38(6), 874-884 (2017-03-07)
The conjugation of small molecular hydrophobic anticancer drugs onto a short peptide with overall hydrophilicity to create self-assembling drug amphiphiles offers a new prodrug strategy, producing well-defined, discrete nanostructures with a high and quantitative drug loading. Here we show the
Martina Tripepi et al.
Bioconjugate chemistry, 29(4), 1428-1437 (2018-02-23)
Molecular imaging requires the specific accumulation of contrast agents at the target. To exploit the superb resolution of MRI for applications in molecular imaging, gadolinium chelates, as the MRI contrast agents (CA), have to be conjugated to a specific vector
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico